Conference Coverage

New research holds promise for fighting obesity, says expert


 

AT INTERNAL MEDICINE 2022

Medication costs are too high for many patients

Isis Smith, MD, an internist at University Medical Center in New Orleans, said in an interview that the cost of the most effective medications – which are not covered by Medicaid – means that many of her patients don’t have access to these treatments.

“We’re talking about $1,000 a month. And so there is no way they can afford [them]. I can prescribe phentermine [but] unless a patient has another indication, Medicaid will not pay for it,” she explained.

“I love hearing about all of the new developments. ... It’s interesting to hear, but we need to get insurance to pay so that I can actually prescribe,” Dr. Smith noted.

Dr. Apovian reports financial relationships with Xeno Biosciences, Cowen, Allergan, Novo Nordisk, Abbott Nutrition, and other companies.

Pages

Recommended Reading

Gastric band failures drive many to safer weight loss surgeries
MDedge Internal Medicine
Be aware of gallbladder, biliary disease with newer obesity drugs
MDedge Internal Medicine
Obesity increasing the risk for cancer: It’s complicated
MDedge Internal Medicine
Type 2 diabetes remission possible for those with lower BMI
MDedge Internal Medicine
AHA statement addresses CVD risk in NAFLD
MDedge Internal Medicine
Bariatric surgery cuts cardiovascular events, even in seniors
MDedge Internal Medicine
Study: Fasting plus calorie counting offered no weight-loss benefit over calorie counting alone
MDedge Internal Medicine
Endoscopic obesity treatments offer alternatives to surgery
MDedge Internal Medicine
It’s time to shame the fat shamers
MDedge Internal Medicine
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
MDedge Internal Medicine